Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NVAX

Novavax, Inc

Sep 12 • 04:00PM ET

7.98

-0.30 -3.62 %

Healthcare • Biotechnology • USA • NASD

Peers: MRNA BNTX PFE JNJ AZN GSK SNY INO NVCR VIR

| Held by: VTI IWM XBI VB VXF IWO VBR IBB VBK SCHA

Scroll to Statements

Index	RUT	P/E	3.54	EPS (ttm)	2.26	Insider Own	8.90%	Shs Outstand	162.16M	Perf Week	1.01%
Market Cap	1.30B	Forward P/E	-	EPS next Y	-0.09	Insider Trans	0.00%	Shs Float	147.97M	Perf Month	-9.83%
Enterprise Value	901.56M	PEG	0.09	EPS next Q	-0.49	Inst Own	58.83%	Short Float	29.65%	Perf Quarter	11.61%
Income	422.82M	P/S	1.20	EPS this Y	302.71%	Inst Trans	4.34%	Short Ratio	6.85	Perf Half Y	-2.33%
Sales	1.08B	P/B	34.39	EPS next Y	-103.77%	ROA	26.80%	Short Interest	43.87M	Perf YTD	-0.75%
Book/sh	0.23	P/C	2.08	EPS next 5Y	38.16%	ROE	-	52W High	15.22 -47.57%	Perf Year	-37.17%
Cash/sh	3.84	P/FCF	-	EPS past 3/5Y	62.54% 25.88%	ROIC	162.27%	52W Low	5.01 59.28%	Perf 3Y	-73.94%
Dividend Est.	-	EV/EBITDA	2.21	Sales past 3/5Y	-15.89% 105.39%	Gross Margin	87.10%	Volatility	4.38% 5.78%	Perf 5Y	-92.25%
Dividend TTM	-	EV/Sales	0.84	EPS Y/Y TTM	198.02%	Oper. Margin	33.96%	ATR (14)	0.47	Perf 10Y	-96.35%
Dividend Ex-Date	Dec 13, 2007	Quick Ratio	2.34	Sales Y/Y TTM	9.22%	Profit Margin	39.20%	RSI (14)	51.74	Recom	2.62
Dividend Gr. 3/5Y	- -	Current Ratio	2.36	EPS Q/Q	-39.59%	SMA20	-1.00%	Beta	2.73	Target Price	12.50
Payout	-	Debt/Eq	6.07	Sales Q/Q	-42.42%	SMA50	4.41%	Rel Volume	1.12	Prev Close	8.28
Employees	952	LT Debt/Eq	5.93	Earnings	Aug 06 BMO	SMA200	4.48%	Avg Volume	6.40M	Price	7.98
IPO	Dec 05, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	7280.95% 56.77%	Trades		Volume	7,152,193	Change	-3.62%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-28-25	Resumed	H.C. Wainwright	Buy	$10
Aug-20-25	Downgrade	BofA Securities	Neutral → Underperform	$7
Jun-17-25	Initiated	Citigroup	Sell	$6
Feb-28-25	Initiated	BTIG Research	Buy	$19
Jul-30-24	Downgrade	JP Morgan	Neutral → Underweight	$8
May-10-24	Upgrade	JP Morgan	Underweight → Neutral
May-10-24	Upgrade	BofA Securities	Underperform → Neutral	$4 → $12
Aug-09-23	Upgrade	B. Riley Securities	Neutral → Buy	$15
Apr-20-23	Downgrade	TD Cowen	Outperform → Market Perform	$55 → $10
Mar-01-23	Downgrade	B. Riley Securities	Buy → Neutral	$29 → $10
Jan-09-23	Reiterated	B. Riley Securities	Buy	$74 → $37
Dec-30-22	Reiterated	H.C. Wainwright	Buy	$207 → $110
Dec-02-22	Initiated	Jefferies	Hold
Sep-22-22	Downgrade	JP Morgan	Neutral → Underweight	$132 → $27
May-20-22	Initiated	BofA Securities	Underperform	$35
Feb-23-22	Reiterated	B. Riley Securities	Buy	$315 → $265
Feb-22-22	Resumed	Jefferies	Buy	$198
Jan-21-22	Initiated	Cowen	Outperform	$150
May-12-21	Downgrade	JP Morgan	Overweight → Neutral	$285 → $161
Dec-14-20	Initiated	Jefferies	Buy	$200

Show Previous Ratings

Sep-12-25 04:21PM	Vaccine Stocks Fall Following Report of Plans to Link Covid Shot With Child Deaths (The Wall Street Journal)
02:11PM	Vaccine Stocks Down Following Report of Plans to Link Covid Shot With Child Deaths (The Wall Street Journal)
12:33PM	Pfizer, Moderna, BioNTech trade lower amid report of vaccine link to child deaths (Investing.com)
Sep-10-25 09:00AM	Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Sep-09-25 08:00PM	Health Officials Hunt for Cases Connecting Covid Shot and Harm in Pregnant Women (The Wall Street Journal)
10:23AM	Loading…
Sep-05-25 10:23AM	Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.? (Investor's Business Daily)
Sep-04-25 08:00AM	Nuvaxovid Now Approved in Japan Triggering Takeda Milestone Payment (PR Newswire) +5.27%
Sep-03-25 08:00AM	Novavax to Participate in the Cantor Global Healthcare Conference (PR Newswire)
Aug-29-25 11:51AM	Boyd Gaming and Shoe Carnival have been highlighted as Zacks Bull and Bear of the Day (Zacks)
05:01AM	Novavax, Inc. (NVAX) Wins FDA Approval for Nuvaxovid BLA (Insider Monkey)
Aug-28-25 12:04PM	FDA Approves Updated COVID-19 Vaccines but With Restrictions (Zacks)
09:50AM	Why Novavax (NVAX) is a Top Momentum Stock for the Long-Term (Zacks)
05:05AM	Novavax, Inc. (NVAX) Launches Protein-Based Vaccine for High-Risk Adults (Insider Monkey)
Aug-27-25 04:27PM	RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles. (Investor's Business Daily)
03:07PM	Novavax's Nuvaxovid 2025-2026 Formula COVID-19 Vaccine Approved in the U.S. (PR Newswire)
01:56PM	Loading…
01:56PM	FDA Approves Pfizer Covid Vaccine but Adds Restrictions on Its Use (Barrons.com)
01:42PM	New Covid-19 Boosters Are Coming Soon. Not Everyone Will Be Eligible to Get One. (The Wall Street Journal)
09:00AM	Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Aug-26-25 08:31PM	Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months' (Benzinga)
Aug-21-25 07:43AM	Novavax Announces Convertible Debt Refinancing (PR Newswire) -12.70%
Aug-20-25 04:23PM	Covid-19 Vaccine Guidelines Are Changing. What We Know About Who Can Get a Shot. (Barrons.com) -8.19%
11:39AM	BofA downgrades Novavax stock on vaccine uncertainty (Investing.com)
09:34AM	Nu double upgraded, Novavax downgraded: Wall Street's top analyst calls (The Fly)
Aug-18-25 11:42PM	Novavax Strengthens Position with Vaccine Approval and Sanofi Partnership (Insider Monkey)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
Aug-13-25 09:00AM	Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know (Zacks)
Aug-12-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks) +5.60%
Aug-07-25 11:14AM	NVAX Stock Gains on Q2 Earnings & Sales Beat, Ups '25 Sales View (Zacks) +15.83%
Aug-06-25 10:48AM	Novavax Ups Outlook, Eyes Stronger Nuvaxovid Sales (Benzinga) +12.63%
09:10AM	Novavax (NVAX) Q2 Earnings and Revenues Top Estimates (Zacks)
09:05AM	Loading…
09:05AM	Novavax lifts 2025 revenue outlook after FDA milestone payment (Investing.com)
08:08AM	Novavax banks on vaccine supply partnerships to boost 2025 revenue (Reuters)
08:07AM	Novavax: Q2 Earnings Snapshot (Associated Press Finance)
08:00AM	Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights (PR Newswire)
Jul-30-25 05:45PM	Novavax (NVAX) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks)
08:00AM	Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025 (PR Newswire)
Jul-28-25 09:00AM	Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock (Zacks)
Jul-24-25 05:45PM	Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
08:00AM	Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study (PR Newswire)
Jul-16-25 09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks)
Jul-14-25 05:45PM	Novavax (NVAX) Rises Higher Than Market: Key Facts (Zacks)
09:00AM	Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? (Zacks)
Jul-13-25 12:27AM	BTIG Maintains a Buy Rating on Novavax (NVAX), Sets a $19 PT (Insider Monkey)
Jul-11-25 10:58AM	MRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric Patients (Zacks)
06:00AM	2 Beaten-Down Stocks That Haven't Hit Rock Bottom Yet (Motley Fool)
Jul-10-25 11:14AM	Citi Initiates Coverage of Novavax (NVAX) With a Sell Rating (Insider Monkey)
Jul-07-25 05:45PM	Novavax (NVAX) Dips More Than Broader Market: What You Should Know (Zacks) +6.51%
Jul-01-25 09:00AM	Is Most-Watched Stock Novavax, Inc. (NVAX) Worth Betting on Now? (Zacks)
06:53AM	Ginkgo Bioworks (DNA) Soars 18.9%: Is Further Upside Left in the Stock? (Zacks)
Jun-27-25 05:45PM	Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
Jun-24-25 08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Jun-20-25 05:45PM	Novavax (NVAX) Ascends While Market Falls: Some Facts to Note (Zacks)
Jun-19-25 09:00AM	Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Jun-18-25 09:51AM	Roku upgraded, Sarepta downgraded: Wall Streets top analyst calls (TipRanks)
Jun-17-25 12:57PM	Citi initiates coverage on biotech amid improving sentiment in sector (Investing.com) -7.68%
Jun-12-25 11:30AM	Why Is Fate Therapeutics (FATE) Up 61.5% Since Last Earnings Report? (Zacks)
08:15AM	Novavax's COVID-Flu Combo Shot Shows Strong Immune Response (Zacks)
Jun-11-25 10:20AM	Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel (TipRanks)
10:20AM	Kennedy Pledges to Immediately Replace Vaccine Advisors, Shortcutting Vetting Process (Barrons.com)
09:50AM	Novavax (NVAX) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
07:11AM	Novavax's COVID-flu combo vaccine shows strong immune response in trial (Reuters)
07:11AM	Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study (Reuters)
07:00AM	Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial (PR Newswire)
Jun-10-25 04:10PM	Vaccine Stocks Mixed After RFK Jr. Fires CDC's Entire Vaccine Committee (Investor's Business Daily)
10:10AM	RFK Jr. removes CDC vaccine panel members: What to know (Yahoo Finance Video)
Jun-09-25 06:07PM	Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr. (Investor's Business Daily)
Jun-06-25 09:00AM	Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks) +6.58%
Jun-03-25 12:16PM	Moderna Secures FDA Nod for Next-Gen COVID-19 Vaccine mNexspike (Zacks)
May-29-25 08:00AM	Novavax to Participate in Upcoming Investor Conferences (PR Newswire)
May-26-25 09:50AM	Here's Why Novavax (NVAX) is a Strong Momentum Stock (Zacks)
09:41AM	MRNA Seeks FDA Nod for Updated COVID-19 Vaccine (Zacks)
09:00AM	Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
May-23-25 07:45AM	Analysts Think These Stocks Could More Than Double in Value (MarketBeat)
May-22-25 02:30PM	FDA panel recommends keeping COVID shots targeted to same strain as last year (BioPharma Dive)
12:35PM	Biotech Stock Roundup: BMRN to Acquire INZY, NVAX Gains on Vaccine Approval & More (Zacks)
10:48AM	MRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo Shot (Zacks)
May-21-25 01:30PM	BofA Reiterates Hold Rating on Novavax (NVAX) Stock (Insider Monkey) -7.42%
11:10AM	FDA to mandate trials for COVID boosters for healthy kids and adults (TipRanks)
May-20-25 03:55PM	COVID vaccine guidelines, D-Wave, Viking Cruises: Trending Tickers (Yahoo Finance Video)
12:22PM	The FDA Is Limiting Covid Shots. But Moderna, Vaccine Stocks Jumped. (Investor's Business Daily)
04:59AM	Company News for May 20, 2025 (Zacks)
04:00AM	The placebo effect: How a new FDA rule could pile more strain onto vaccine developers (Pharma Voice)
May-19-25 05:18PM	S&P 500 Gains & Losses Today: Solar Stocks Fall, UnitedHealth Shares Jump (Investopedia) +15.01%
04:30PM	JPMorgan Maintains Underweight Rating on Novavax (NVAX) Stock Despite Positive News (Insider Monkey)
03:44PM	Novavax, Shake Shack, solar stocks: Trending Tickers (Yahoo Finance Video)
03:42PM	Novavax Shares Jump 17% FDA Grants Full Approval to COVID Vaccine (GuruFocus.com)
11:55AM	Top Stock Movers Now: Tesla, AutoZone, Novavax, and More (Investopedia)
10:46AM	Coinbase on S&P 500, Novavax vaccine, Tesla: Trending Tickers (Yahoo Finance Video)
10:30AM	Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker. (Barrons.com)
09:43AM	RFK Jr. pledged not to upend US vaccine system, but big changes are underway (Associated Press Finance)
09:42AM	NVAX Stock Surges on Securing FDA Approval for COVID-19 Vaccine (Zacks)
09:39AM	Novavax Stock Soars on FDA Approval for New COVID-19 Vaccine (Investopedia)
07:16AM	Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine (Reuters)
07:00AM	U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine (PR Newswire)
May-18-25 08:53PM	FDA Clears Novavax, Inc. (NVAX)'s COVID-19 Vaccine with Usage Restrictions (Insider Monkey)
May-17-25 10:21PM	FDA approves Novavax COVID-19 shot but with unusual restrictions (Associated Press Finance)
May-13-25 09:00AM	Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
May-09-25 09:50AM	Why Novavax (NVAX) is a Top Momentum Stock for the Long-Term (Zacks) -10.29%
08:55AM	NVAX Stock Gains 12% on Q1 Earnings & Sales Beat, '25 Sales View Up (Zacks)
03:13AM	Novavax Inc (NVAX) Q1 2025 Earnings Call Highlights: Revenue Surge Amid Strategic Partnerships ... (GuruFocus.com)

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MCGLYNN MARGARET G	Director	Jun 12 '25	Option Exercise	0.00	10,420	0	25,588	Jun 16 04:10 PM
Alton Gregg H	Director	Jun 12 '25	Option Exercise	0.00	10,420	0	28,805	Jun 16 04:09 PM
King Rachel K.	Director	Jun 12 '25	Option Exercise	0.00	10,420	0	25,190	Jun 13 09:41 PM
Rodgers Richard J	Director	Jun 12 '25	Option Exercise	0.00	10,420	0	24,690	Jun 13 09:40 PM
MOTT DAVID M	Director	Jun 12 '25	Option Exercise	0.00	10,420	0	60,890	Jun 13 09:39 PM
DOUGLAS RICHARD	Director	Jun 12 '25	Option Exercise	0.00	10,420	0	54,340	Jun 13 09:36 PM
YOUNG JAMES F	Former Director	May 19 '25	Proposed Sale	7.59	10,000	75,883		May 19 04:37 PM
YOUNG JAMES F	Former Director	Apr 14 '25	Proposed Sale	6.10	4,000	24,406		Apr 14 04:19 PM
Trizzino John	President and COO	Mar 07 '25	Option Exercise	0.00	28,890	0	82,015	Mar 11 04:34 PM
Kelly James Patrick	EVP, CFO and Treasurer	Mar 07 '25	Option Exercise	0.00	12,223	0	75,155	Mar 11 04:33 PM
Trizzino John	President and COO	Mar 01 '25	Option Exercise	0.00	48,000	0	76,310	Mar 04 06:47 PM
Casey Mark J	EVP, Chief Legal Officer	Mar 01 '25	Option Exercise	0.00	4,000	0	33,187	Mar 04 06:46 PM
Kelly James Patrick	EVP, CFO and Treasurer	Mar 01 '25	Option Exercise	0.00	58,667	0	91,269	Mar 04 06:43 PM
Jacobs John C	President and CEO	Mar 01 '25	Option Exercise	0.00	83,334	0	175,183	Mar 04 06:42 PM
O'Hara Elaine	EVP, Chief Strategy Officer	Mar 01 '25	Option Exercise	0.00	59,600	0	73,825	Mar 04 06:39 PM
Jacobs John C	President and CEO	Jan 23 '25	Option Exercise	0.00	83,196	0	130,722	Jan 27 06:19 PM
Kelly James Patrick	EVP, CFO and Treasurer	Dec 31 '24	Option Exercise	0.00	35,000	0	49,508	Jan 03 05:41 PM
Rodgers Richard J	Director	Oct 29 '24	Option Exercise	0.00	3,800	0	14,270	Jan 02 04:52 PM
King Rachel K.	Director	Dec 13 '24	Sale	9.02	4,150	37,435	14,770	Jan 02 04:47 PM
YOUNG JAMES F	Director	Dec 31 '24	Sale	8.00	5,400	43,200	51,760	Jan 02 04:44 PM
YOUNG JAMES F	Director	Dec 24 '24	Sale	8.48	4,600	39,008	57,160	Jan 02 04:44 PM
YOUNG JAMES F	Director	Dec 24 '24	Proposed Sale	8.48	10,000	84,800		Dec 26 10:31 AM
Casey Mark J	EVP, Chief Legal Officer	Dec 11 '24	Option Exercise	0.00	41,900	0	41,900	Dec 13 05:24 PM
Rachel K. King	Board Member	Dec 13 '24	Proposed Sale	9.00	4,150	37,350		Dec 13 12:13 PM
Dubovsky Filip	Officer	Sep 18 '24	Proposed Sale	13.00	7,335	95,331		Sep 18 04:08 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVAX

Novavax, Inc

Upgrade your FINVIZ experience